Advertisement
Research Article| Volume 12, ISSUE 4, P787-803, December 1992

Inactivation Of Microbial Contaminants Of Blood Components

DOI:https://doi.org/10.1016/S0272-2712(18)30488-8
Inactivation Of Microbial Contaminants Of Blood Components
Previous ArticleLimiting Homologous Blood Exposure
Next ArticleLegal Issues in Transfusion Medicine: Is Blood Banking a Medical Profession?
      This paper is only available as a PDF. To read, Please Download here.
      Despite the low risk of transfusion-transmitted infection currently present in the blood supply, processes to inactivate con-taminating viruses and bacteria may improve the safety of transfusion even further. A variety of techniques, using both physical and chemical processes, are being explored. Particularly promising is adaptation of the solvent/detergent technique (already in use for plasma derivatives) to plasma for transfusion. Inactivation of viruses in cellular components may require a combination of techniques, possibly including leukocyte depletion filtration, photoactive compounds, and subsequent washing. Concerns about potential toxicity of the agents employed and retention of component efficacy after treatment and storage remain unresolved, however.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Aloisio C.H.
        • Nicholson J.K.
        Recovery of infectious human immunodeficiency virus from cells treated with 1% paraformaldehyde.
        J Immunol Methods. 1990; 128: 281-285
        • Alter H.J.
        • Morel P.A.
        • Dorman B.P.
        • et al.
        Photochemical decontamination of blood components containing hepatitis B and non-A, non-B virus.
        Lancet. 1988; 2: 1446-1450
        • Alter H.V.
        • Tabor E.
        • Meryman H.T.
        • et al.
        Transmission of hepatitis B virus infection by transfusion of frozen deglycerolized red blood cells.
        N Engl J Med. 1978; 298: 637-642
        • Andreu G.
        Role of leukocyte depletion in the prevention of transfusion-induced cytomegalovirus infection.
        Semin Flematol. 1991; 28: 26-31
        • AuBuchon J.P.
        • Dzik W.
        Survival of Loa loa in banked blood [letter].
        Lancet. 1983; 1: 647-648
        • Bhupat R.
        • Yen T.S.
        • Vyas G.
        • et al.
        Leukocyte filtration removes infectious particulate debris but not free virus derived from experimentally lysed HIV-infected cells.
        Vox Sang. 1991; 60: 214-218
        • Bigbee P.D.
        • Sarin P.S.
        • Humphreys J.C.
        • et al.
        Inactivation of human immunodeficiency virus (HIV) by ionizing radiation in body fluids and serological evidence.
        J Forensic sci. 1989; 34: 1303-1310
        • Bowden R.A.
        • Slichter S.J.
        • Sayers M.H.
        • et al.
        Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant.
        Blood. 1991; 78: 246-250
        • Buchholz D.H.
        • AuBuchon J.P.
        • Snyder E.
        • et al.
        Leukocyte depletion and bacterial proliferation in blood components [abstract].
        Transfusion. 1991; 31: 63S
        • Buchholz D.H.
        • Snyder E.
        • AuBuchon J.P.
        • et al.
        Proliferation of Yersinia enterocolitica in leukodepleted and non-depleted red cells [abstract].
        Transfusion. 1991; 31: 63S
        • Burnouf-Radosevich M.
        • Burnouf T.
        • Huart J.J.
        Biochemical and physical properties of a solvent-detergent-treated fibrin glue.
        Vox Sang. 1990; 58: 77-84
        • Carmen R.
        • Koller E.
        • Leng B.
        • et al.
        Growth of Yersinia enterocolitica in AS-3 red cells: Effect of filtration prior to storage [abstract].
        Transfusion. 1991; 31: 16S
        • Chandra P.
        • Wacker A.
        Photodynamic effects on the template activity of nucleic acids.
        Z Naturforsch. 1966; 21b: 663-666
        • Chanh T.C.
        • Allen J.S.
        • Mattheews J.L.
        • et al.
        Photodynamic inactivation of simian immunodeficiency virus.
        J Virol Methods. 1989; 26: 125-131
        • Cole M.
        • Stromberg R.
        • Friedman L.
        • et al.
        Photochemical inactivation of virus in red cells [abstract].
        Transfusion. 1989; 29: 42S
        • Cummins D.
        • Southee T.
        • Walshe K.
        • et al.
        Gamma irradiated blood samples: Unsuitability for haemostatic evaluation of high risk patients [letter].
        J Clin Pathol. 1989; 42: 667
        • de Graan-Hentzen Y.C.E.
        • Gratama J.W.
        • Mudde G.C.
        • et al.
        Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products.
        Transfusion. 1989; 29: 757-760
        • de Witte T.
        • Schattenberg A.
        • van Dijk B.A.
        • et al.
        Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood-bank donors.
        Transplantation. 1990; 50: 964-968
        • Dodd R.
        Will blood products be free of infectious agents?.
        in: Nance S.J. Transusion Medicine in the 1990s. American Association of Blood Banks, Arlington, VA1990
        • Dodd R.Y.
        • Moroff G.
        • Wagner S.
        • et al.
        Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: Comparison of psoralen-ultraviolet A and merocyanine 540-visible light methods.
        Transfusion. 1991; 31: 483-490
        • Edwards C.A.
        • Piet M.P.J.
        • Chin S.
        • et al.
        Tri(n-butyl) phosphate/detergent treatment of licensed therapeutic and experimental blood derivatives.
        Vox Sang. 1987; 52: 53-59
        • Eichler D.C.
        • Solomonson L.P.
        • Barber M.J.
        • et al.
        Radiation inactivation analysis of enzymes.
        J Biol Chem. 1987; 262: 9433-9436
        • Estep T.N.
        • Bechtel M.K.
        • Miller T.J.
        • et al.
        Virus inactivation in hemoglobin solutions by heat.
        Biomaterials Artif Cells. 1988; 16: 129-134
        • Fratantoni J.C.
        • Prodouz K.N.
        • Horowitz M.S.
        Viral inactivation of blood products [editorial].
        Transfusion. 1990; 30: 480-481
        • Geyer S.J.
        • Blay R.
        • Epstein J.S.
        Rate of HIV-1 inactivation in packed red cells stored at 1-6°C in CPDA and ADSOL [abstract].
        Transfusion. 1991; 31: 475
        • Gilbert G.
        • Hayes K.
        • Hudson I.
        • et al.
        Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes.
        Lancet. 1989; 1: 1228-1231
        • Gomperts E.
        Procedures for the inactivation of viruses in clotting factor concentrates.
        Am J Hematol. 1986; 23: 295-305
        • Hamamoto Y.
        • Harada S.
        • Kobayashi S.
        • et al.
        A novel method for removal of immunodeficiency virus: Filtration with porous polymeric membranes.
        Vox Sang. 1989; 56: 230-236
        • Haugen R.K.
        Hepatitis after the transfusion of frozen red cells and washed red cells.
        N Engl J Med. 1979; 301: 393-395
        • Hiemstra H.
        • Tersmette M.
        • Vos A.H.
        • et al.
        Inactivation of human immunodeficiency virus by gamma radiation and its effect on plasma and coagulation factors.
        Transfusion. 1991; 31: 32-39
        • Horowitz B.
        Blood protein derivative viral safety: Observations and analysis.
        Yale J Biol Med. 1990; 63: 361-369
        • Horowitz B.
        Potential accumulation of tri(n-butyl)phosphate in solvent-detergent virus-inactivated plasma products [letter].
        Transfusion. 1992; 31: 871
        • Horowitz B.
        • Bonomo R.
        • Prince A.M.
        • et al.
        Solvent/detergent-treated plasma: A virusinactivated substitute for fresh frozen plasma.
        Blood. 1992; 79: 826-831
        • Horowitz B.
        • Piet M.P.
        • Prince A.M.
        • et al.
        Inactivation of lipid-enveloped viruses in labile blood derivatives by unsaturated fatty acids.
        Vox Sang. 1988; 54: 14-20
        • Horowitz B.
        • Wiebe M.E.
        • Lippin A.
        • et al.
        Inactivation of viruses in labile blood derivatives. I. Disruption of lipid-enveloped viruses by tri(n-butyl) phosphate detergent combinations.
        Transfusion. 1985; 25: 516-522
        • Horowitz B.
        • Wiebe M.E.
        • Lippin A.
        • et al.
        Inactivation of viruses in labile blood derivatives. II. Physical methods.
        Transfusion. 1985; 25: 523-527
        • Horowitz B.
        • Williams B.
        • Rywkin S.
        • et al.
        Inactivation of viruses in blood with aluminum phthalocyanine derivatives.
        Transfusion. 1991; 31: 102-108
        • Isaacs S.T.
        • Shen C.J.
        • Hearst J.E.
        • et al.
        Synthesis and characterization of new psoralen derivatives with superior photoreactivity with DNA and RNA.
        Biochemistry. 1977; 16: 1058-1064
        • Kalyanaraman B.
        • Sieber F.
        On the mechanism of merocyanine 540-mediated photosensitization.
        Photochem Photobiol. 1986; 43: 28s
        • Kanne D.
        • Straub K.
        • Rapoport H.
        • et al.
        Psoralen-DNA photoreaction: Characterization of the monaddition products from 8-methoxypsoralen and 4,5’,8-trimethoxypsoralen.
        Biochemistry. 1982; 21: 861-871
        • Kitchen A.D.
        • Mann G.F.
        • Harrison J.F.
        • et al.
        Effect of gamma irradiation on the human immunodeficiency virus and human coagulation proteins.
        Vox Sang. 1989; 56: 223-229
        • Lambrecht B.
        • Mohr H.
        • Knuver-Hopf J.
        • et al.
        Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light.
        Vox Sang. 1991; 60: 207-213
        • Lin L.
        • Wiesehahn G.P.
        • Morel P.A.
        • et al.
        Use of 8-methoxypsoralen and longwavelength ultraviolet radiation for decontamination of platelet concentrates.
        Blood. 1989; 74: 517-529
        • LoGrippo G.A.
        • Basinski D.H.
        • Rupe C.E.
        Virus infected erythrocytes sterilized with Betaprone (BPL). I. Effect on in vitro storage and in vivo survival.
        Vox Sang. 1963; 8: 497-504
        • LoGrippo G.A.
        • Hartman F.W.
        Chemical and combined methods for plasma sterilization.
        Bibl Haematol. 1958; 7: 225-230
        • Matthews J.L.
        • Newman J.T.
        • Sogandares-Bernal F.
        • et al.
        Photodynamic therapy of viral contaminants with potential for blood banking applications.
        Transfusion. 1988; 28: 81
        • Matthews J.L.
        • Sogandares-Bernal F.
        • Judy M.M.
        • et al.
        Preliminary studies of photoinactivation of human immunodeficiency virus in blood.
        Transfusion. 1991; 31: 636-641
        • Merkle W.
        • Mauler R.
        Biometrical aspects in the design and analysis of chimpanzee trials assessing hepatitis virus inactivation.
        Arzneimittel-Forschung Drug Res. 1987; 37: 763-769

      49. Meryman HT, Yoshinari M, Tokunaga E, et al: Post transfusion hepatitis following transfusion with packed cells, saline washed cells or frozen deglycerolized cells. In Proceedings of the ISH-ISBT, Montreal, 1980, p 155

        • Michaelis B.
        • Levy J.A.
        Recovery of human immunodeficiency virus from serum [letter].
        JAMA. 1987; 257: 1327
        • Mitchel S.W.
        • McCormick J.B.
        Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and the effect on clinical laboratory analyses.
        J Clin Microbiol. 1984; 20: 486-489
        • Moroff G.
        • Benade L.E.
        • Dabay M.
        • et al.
        Use of photochemical procedures to inactivate viruses in platelet suspensions [abstract].
        Transfusion. 1989; 29: 9S
        • Moroff G.
        • George V.M.
        • Siegl A.M.
        • et al.
        The influence of irradiation on stored platelets.
        Transfusion. 1986; 26: 453-456
        • Morrow J.F.
        • Braine H.G.
        • Kickler T.S.
        • et al.
        Septic reactions to platelet transfusions: A persistent problem.
        JAMA. 1991; 266: 555-558
        • Murray R.
        • Oliphant J.W.
        • Tripp J.T.
        • et al.
        Effect of ultraviolet radiation on the infectivity of icterogenic plasma.
        JAMA. 1955; 57: 8-14
        • Neurath A.R.
        • Vernon S.K.
        • Dobkin M.B.
        • et al.
        Characterization of subviral components resulting from treatment of rabies virus with tri(n-butyl)phosphate.
        J Gen Virol. 1972; 14: 33-48
        • Neyndorff H.C.
        • Bartel D.L.
        • Tufaro F.
        • et al.
        Development of a model to demonstrate photosensitizer-mediated viral inactivation in blood.
        Transfusion. 1990; 30: 485-490
        • North J.
        • Freeman S.
        • Overbaugh J.
        • et al.
        Photodynamic inactivation of retrovirus by benzoporphyrin derivative: A feline leukemia virus model.
        Transfusion. 1992; 32: 121-128
        • O’Brien J.M.
        • Montgomery R.R.
        • Burns W.H.
        • et al.
        Evaluation of merocyanine 540-sensitized photoirradiation as a means to inactivate enveloped viruses in blood products.
        J Lab Clin Med. 1990; 116: 439-447
        • O’Brien J.M.
        • Sieber F.
        Mutagenicity of merocyanine 540-mediated photosensitization.
        Exp Hematol. 1989; 17: 166-170
        • Peckler S.
        • Graves B.
        • Kanne D.
        • et al.
        Structure of a psoralen-thymine monoadduct formed in photoreaction with DNA.
        J Mol Biol. 1982; 162: 157-172

      62. Pickard C, AuBuchon JP: Observations and experiences in the study of bacterial growth in blood components. Presented at the Research and Progress Session, American Association of Blood Banks Annual Meeting, Baltimore, November, 1991

        • Piet M.P.
        • Chin S.
        • Prince A.M.
        • et al.
        The use of tri-(n-butyl) phosphate detergent mixtures to inactivate hepatitis viruses and human immunodeficiency virus in plasma and plasma’s subsequent fractionation.
        Transfusion. 1990; 30: 591-598
        • Piszkiewicz D.
        • Tondreau S.C.
        Inactivation of HIV-2 by solvent/detergent treatment [letter].
        Transfusion. 1990; 30: 192
        • Prince A.M.
        • Horowitz B.
        • Brotman B.
        Sterilisation of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate.
        Lancet. 1986; 1: 706-710
        • Prodouz K.N.
        • Fratantoni J.C.
        • Boone E.J.
        • et al.
        Use of laser-UV inactivation of virus in blood products.
        Blood. 1987; 70: 589-592
        • Prodouz K.N.
        • Lytle C.D.
        • Keville E.A.
        • et al.
        Inhibition by albumin of merocyanine 540-mediated photosensitization of platelets and viruses.
        Transfusion. 1991; 31: 415-422
        • Rawal B.D.
        • Babu P.G.
        • Sharma Y.
        • et al.
        Chemical approach for inactivation of cell-free viruses in blood [abstract].
        Transfusion. 1991; 31: 48S
        • Rawal B.D.
        • Busch M.P.
        • Endow R.
        • et al.
        Reduction of human immunodeficiency virusinfected cells from donor blood by leukocyte filtration.
        Transfusion. 1989; 29: 460-462
        • Redfield D.C.
        • Richman D.D.
        • Oxman M.C.
        • et al.
        Psoralen inactivation of influenza and herpes simplex viruses and of virus-infected cells.
        Infect Immunol. 1981; 32: 1216-1226
        • Schneider J.E.
        • Price S.
        • Maidt L.
        • et al.
        Methylene blue plus light mediates 8-hydroxy 2’-deoxyguanosine formation in DNA preferentially over strand breakage.
        Nucl Acid Res. 1990; 18: 631-635
        • Seidl S.
        • Kuhnl P.
        Viral diseases transmissible by blood transfusion.
        in: Greenwalt T.J. Blood Transfusion. Churchill Livingstone, New York1988
        • Sieber F.
        • O’Brien J.M.
        • Krueger G.J.
        • et al.
        Antiviral activity of merocyanine 540.
        Photochem Photobiol. 1987; 46: 707-711
        • Singer C.R.J.
        • Azim T.
        • Sattentau O.
        Preliminary evaluation of phthalocyanine photosensitisation for inactivation of viral pathogens in blood products [abstract].
        Br J Hematol. 1988; 69: 111
        • Stern R.S.
        • Laird N.
        • Melski J.
        • et al.
        Cutaneous squamous-cell carcinoma in patients treated with PUVA.
        N Engl J Med. 1984; 310: 1156-1161
        • Sullivan R.
        • Fassolitis A.C.
        • Larkin E.P.
        • et al.
        Inactivation of thirty viruses by gamma radiation.
        Appl Microbiol. 1971; 22: 61-65
        • Tsao I.F.
        • Shipman C.
        • Wang H.
        The removal of adventitious viruses and virus-infected cells using cellular adsorbent: A feasibility study.
        Biotechnology. 1989; 6: 1330-1333

      78. Ulrich PP, El-Beik T, Busch MP, et al: Human immunodeficiency virus (HIV) cultured from limiting dilutions of the peripheral blood mononuclear cells (PBMC) of asymptomatic seropositive persons. In Proceedings of the Third International Conference on AIDS, Washington, DC, 1987, p 108

        • Valenzeno D.P.
        • Trudgen J.
        • Hutzenbuhler A.
        • et al.
        Singlet oxygen involvement in photohemolysis sensitized by merocyanine-540 and rose bengal.
        Photochem Photobiol. 1987; 46: 985-990
        • Wagner S.J.
        • Friedman L.I.
        • Dodd R.Y.
        Bacteriocidal effect of gentamicin against Yersinia spiked into Adsol red cells [abstract].
        Transfusion. 1991; 31: 16S
        • Wagner S.J.
        • Storry J.
        • Mallory D.
        • et al.
        Red cell surface alterations resulting from virucidal photochemical treatment [abstract].
        Transfusion. 1991; 31: 48S
        • Wagner S.J.
        • Wagner K.F.
        • Friedman L.I.
        • et al.
        Virucidal levels of ozone induce hemolysis and hemoglobin degradation.
        Transfusion. 1991; 31: 748-751
        • Ward R.L.
        Mechanisms of poliovirus inactivation by the direct and indirect effects of ionizing radiation.
        Radiat Res. 1980; 83: 330-344
        • Watson A.J.
        • Klaniecki J.
        • Hanson C.V.
        Psoralen/UV inactivation of HIV-l-infected cells for use in cytologic and immunologic procedures.
        AIDS Res Human Retrovir. 1990; 6: 503-513
        • Wells K.H.
        • Latino J.
        • Gavalchin J.
        • et al.
        Inactivation of human immunodeficiency virus type 1 by ozone in vitro.
        Blood. 1991; 78: 1882-1890
        • Wilhelm J.A.
        • Matter L.
        • Schopfer K.
        The risk of transmitting cytomegalovirus to patients receiving blood transfusion.
        J Infect Dis. 1986; 154: 169-171
        • Zimmerman T.S.
        Factor VIII/von Willebrand factor: Structure and function.
        Ann NY Acad sci. 1987; 509: 53-59
        • Zuck T.F.
        Greetings—a final look back with comments about a policy of a zero-risk blood supply [editorial].
        Transfusion. 1987; 27: 447-448

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30488-8

      Copyright

      © 1992 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX